EDN1 and cancer: This is an interesting avenue through which to target ET-1 expression and poses the question of whether this strategy could be used to enrich EVs with alternative miRNA to regulate the repression of ET-1, preventing the upregulation of many cancer-promoting pathways that ET-1 is involved in.